Patients should always seek the advice of a doctor or pharmacist in case of adverse events.
If you wish to report an adverse event to ELC Group s.r.o., please find the contact information below:
To contact us about any other issue please call:
Pacienti by meli vždy požádat o radu svého lékare nebo lékárníka v prípade výskytu nežádoucích príhod.
Pokud chcete nahlásit nežádoucí príhodu spolecnosti ELC Group s r.o., prosím využijte kontaktních údaju níže:
Pro záležitosti, které se netýkaji farmakovigilance, kontaktujte prosím recepci:
+420 22 491 0000 nebo naše další pobočky.
On Thursday 12th November 2020, at 11:00 CET (Central European Time, GMT+2), ELC will be hosting a webinar providing an overview on BREXIT – What to Expect from the Regulatory and Pharmacovigilance Perspectives
The presenters will be Marco Rubinstein, CEO of ELC Group, Dr. Prashanth BSB, Medical Writing and EUQPPV in ELC Group and Vikash Patel, Senior Regulatory Consultant.
We are going to take you through the following topics:
Please note that the number of participants is limited.
